MYC and hepatocellular carcinoma: It is also evident by our analysis that the expression levels of WNT3/3a, β-CATENIN, C-MYC, GLI2, PTCH1, SHH were maximum during the stage3a and 3b of HCC patients (Fig 6C), which corroborates our in vivo findings.